The diagnostic value of bronchodilator response in differentiating asthma, COPD, and ACO in fixed airflow obstruction: a retrospective study

Abstract Background An accurate distinction between asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with fixed airflow obstruction (FAO) is crucial for optimizing treatment strategies and improving clinical outcomes. The role of bronchodilator response...

Full description

Saved in:
Bibliographic Details
Main Authors: Müge Erbay, Olcay Ayçiçek, Aleyna Bektaş Hocek, Kübra Nur Özdemir
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12890-025-03764-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849769538672918528
author Müge Erbay
Olcay Ayçiçek
Aleyna Bektaş Hocek
Kübra Nur Özdemir
author_facet Müge Erbay
Olcay Ayçiçek
Aleyna Bektaş Hocek
Kübra Nur Özdemir
author_sort Müge Erbay
collection DOAJ
description Abstract Background An accurate distinction between asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with fixed airflow obstruction (FAO) is crucial for optimizing treatment strategies and improving clinical outcomes. The role of bronchodilator response in differentiating between these diseases is unclear. We aimed to identify factors that could aid in differential diagnosis. Methods This study employed a single-center, retrospective cohort design at a tertiary referral hospital. Patients with fixed airway obstruction, characterized by a post-bronchodilator FEV1/FVC ratio < 0.7 or below the lower limit of normal spirometry, were included. Receiver operating curve analysis (ROC) was used to evaluate the optimal cutoff values for spirometric data, with the goal of differentiating between ACO patients and those with asthma or COPD. Univariable and multivariable binary logistic regression models were employed to identify the demographic and clinical characteristics associated with ACO. Results Of 301 patients, 41.2% had asthma, 43.9% had COPD, and 15% had ACO. Of the participants 66.4% were male, and the mean age was 61.2 ± 14.3 years. The bronchodilator response (BDR) was significantly higher in the ACO group (280 mL) than in the asthma (190 mL) and COPD (120 mL) groups (p < 0.001). BDR (%) was associated with ACO in both univariate (OR 1.056; 95% CI 1.028–1.084; p < 0.001) and multivariate analyses (OR 1.05; 95% CI 1.01–1.09; p = 0.01). The BDR (ml) had the highest AUC (0.702; p < 0.001), suggesting that it is a moderately predictive diagnostic parameter with a cutoff of ≥ 280 ml (sensitivity: 55.56%; specificity: 77.73%). FEV1 (L) and FEV1/FVC (%) also demonstrated moderate diagnostic values with AUCs of 0.625 and 0.594, respectively. Conclusions This study provides practical cutoff values for BDR, aiding clinicians in distinguishing between overlapping respiratory diseases in a tertiary care settings. An identified BDR cutoff of ≥ 280 mL could serve as a practical tool for distinguishing ACO.
format Article
id doaj-art-b3c655bb92d0401aa61a5d9e5a0cab89
institution DOAJ
issn 1471-2466
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Pulmonary Medicine
spelling doaj-art-b3c655bb92d0401aa61a5d9e5a0cab892025-08-20T03:03:23ZengBMCBMC Pulmonary Medicine1471-24662025-07-012511910.1186/s12890-025-03764-0The diagnostic value of bronchodilator response in differentiating asthma, COPD, and ACO in fixed airflow obstruction: a retrospective studyMüge Erbay0Olcay Ayçiçek1Aleyna Bektaş Hocek2Kübra Nur Özdemir3Section of Immunology and Allergy Diseases, Department of Chest Diseases, Medical Faculty, Karadeniz Technical UniversityDepartment of Chest Diseases, Medical Faculty, Karadeniz Technical UniversityDepartment of Chest Diseases, Medical Faculty, Karadeniz Technical UniversityDepartment of Chest Diseases, Medical Faculty, Karadeniz Technical UniversityAbstract Background An accurate distinction between asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with fixed airflow obstruction (FAO) is crucial for optimizing treatment strategies and improving clinical outcomes. The role of bronchodilator response in differentiating between these diseases is unclear. We aimed to identify factors that could aid in differential diagnosis. Methods This study employed a single-center, retrospective cohort design at a tertiary referral hospital. Patients with fixed airway obstruction, characterized by a post-bronchodilator FEV1/FVC ratio < 0.7 or below the lower limit of normal spirometry, were included. Receiver operating curve analysis (ROC) was used to evaluate the optimal cutoff values for spirometric data, with the goal of differentiating between ACO patients and those with asthma or COPD. Univariable and multivariable binary logistic regression models were employed to identify the demographic and clinical characteristics associated with ACO. Results Of 301 patients, 41.2% had asthma, 43.9% had COPD, and 15% had ACO. Of the participants 66.4% were male, and the mean age was 61.2 ± 14.3 years. The bronchodilator response (BDR) was significantly higher in the ACO group (280 mL) than in the asthma (190 mL) and COPD (120 mL) groups (p < 0.001). BDR (%) was associated with ACO in both univariate (OR 1.056; 95% CI 1.028–1.084; p < 0.001) and multivariate analyses (OR 1.05; 95% CI 1.01–1.09; p = 0.01). The BDR (ml) had the highest AUC (0.702; p < 0.001), suggesting that it is a moderately predictive diagnostic parameter with a cutoff of ≥ 280 ml (sensitivity: 55.56%; specificity: 77.73%). FEV1 (L) and FEV1/FVC (%) also demonstrated moderate diagnostic values with AUCs of 0.625 and 0.594, respectively. Conclusions This study provides practical cutoff values for BDR, aiding clinicians in distinguishing between overlapping respiratory diseases in a tertiary care settings. An identified BDR cutoff of ≥ 280 mL could serve as a practical tool for distinguishing ACO.https://doi.org/10.1186/s12890-025-03764-0Bronchodilator responseSpirometryFixed airway obstructionAsthmaChronic obstructive pulmonary diseaseAsthma-COPD overlap
spellingShingle Müge Erbay
Olcay Ayçiçek
Aleyna Bektaş Hocek
Kübra Nur Özdemir
The diagnostic value of bronchodilator response in differentiating asthma, COPD, and ACO in fixed airflow obstruction: a retrospective study
BMC Pulmonary Medicine
Bronchodilator response
Spirometry
Fixed airway obstruction
Asthma
Chronic obstructive pulmonary disease
Asthma-COPD overlap
title The diagnostic value of bronchodilator response in differentiating asthma, COPD, and ACO in fixed airflow obstruction: a retrospective study
title_full The diagnostic value of bronchodilator response in differentiating asthma, COPD, and ACO in fixed airflow obstruction: a retrospective study
title_fullStr The diagnostic value of bronchodilator response in differentiating asthma, COPD, and ACO in fixed airflow obstruction: a retrospective study
title_full_unstemmed The diagnostic value of bronchodilator response in differentiating asthma, COPD, and ACO in fixed airflow obstruction: a retrospective study
title_short The diagnostic value of bronchodilator response in differentiating asthma, COPD, and ACO in fixed airflow obstruction: a retrospective study
title_sort diagnostic value of bronchodilator response in differentiating asthma copd and aco in fixed airflow obstruction a retrospective study
topic Bronchodilator response
Spirometry
Fixed airway obstruction
Asthma
Chronic obstructive pulmonary disease
Asthma-COPD overlap
url https://doi.org/10.1186/s12890-025-03764-0
work_keys_str_mv AT mugeerbay thediagnosticvalueofbronchodilatorresponseindifferentiatingasthmacopdandacoinfixedairflowobstructionaretrospectivestudy
AT olcayaycicek thediagnosticvalueofbronchodilatorresponseindifferentiatingasthmacopdandacoinfixedairflowobstructionaretrospectivestudy
AT aleynabektashocek thediagnosticvalueofbronchodilatorresponseindifferentiatingasthmacopdandacoinfixedairflowobstructionaretrospectivestudy
AT kubranurozdemir thediagnosticvalueofbronchodilatorresponseindifferentiatingasthmacopdandacoinfixedairflowobstructionaretrospectivestudy
AT mugeerbay diagnosticvalueofbronchodilatorresponseindifferentiatingasthmacopdandacoinfixedairflowobstructionaretrospectivestudy
AT olcayaycicek diagnosticvalueofbronchodilatorresponseindifferentiatingasthmacopdandacoinfixedairflowobstructionaretrospectivestudy
AT aleynabektashocek diagnosticvalueofbronchodilatorresponseindifferentiatingasthmacopdandacoinfixedairflowobstructionaretrospectivestudy
AT kubranurozdemir diagnosticvalueofbronchodilatorresponseindifferentiatingasthmacopdandacoinfixedairflowobstructionaretrospectivestudy